Value Added Services

23.10.2025 • Topics • Bioprocessing

A Balanced Model for the Future of Life Sciences

Following the acquisition of MCE Pharma Brenntag is building a unique position in both traditional pharma and biopharma.

Top-Feature

Bio-Rad Laboratories

A successful concept on course for expansion — maintenance Munich 2025

Free Expert Insights

Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Brenntag SE

Value Added Services

A Balanced Model for the Future of Life Sciences

Top-Feature

Dual‑Targeting Breakthroughs: Advancements in Bispecific Antibody Development

20 Years of CHEManager International

Brenntag Downsizes Management Board, Retains Both Divisions

Advanced Recycling Conference 2025: New Paths to the Circular Economy

ECA Foundation Aims to Become Largest Pharma Association for GMP/GDP Compliance

A successful concept on course for expansion — maintenance Munich 2025

Free Expert Insights

Dual‑Targeting Breakthroughs

Newsletter & e-edition